The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The purpose of this meta-analysis was to evaluate the efficacy and safety of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, in addition to standard anticancer therapy. Randomized controlled trials (RCTs) that evaluated the efficacy and safety of celecoxib-combined cancer therapy were sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Shi-Yu, Li, Jia-Yi, Li, Teng-Hui, Song, Yong-Xi, Sun, Jing-Xu, Chen, Xiao-Wan, Zhao, Jun-Hua, Li, Yuan, Wu, Zhong-Hua, Gao, Peng, Huang, Xuan-Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497539/
https://www.ncbi.nlm.nih.gov/pubmed/36135051
http://dx.doi.org/10.3390/curroncol29090482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497539/
https://www.ncbi.nlm.nih.gov/pubmed/36135051
http://dx.doi.org/10.3390/curroncol29090482

Ejemplares similares